April 15, 2021
The Japanese government should set API-by-API targets for the use of biosimilars in its 2021 Basic Policy on Economic and Fiscal Management and Reform ( honebuto ) to be compiled this summer, urges Masaki Muto, president of the Japanese Society...read more